申请人:Takeda Chemical Industries, Ltd.
公开号:US06627651B1
公开(公告)日:2003-09-30
Compounds of general formula (1)
R1—X1—W—X2—Z1—Z2—R2
or salts thereof, exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group represented by, e. g., general formula (2)
(wherein A and B are each an optionally substituted five- to seven-membered ring; E1 and E4 are each optionally substituted carbon or the like; E2 and E3 are each oxygen or the like; and a and b are each a single bond or a double bond); X2 is a divalent group constituting a straight chain moiety; Z1 is a divalent cyclic group or the like; Z2 is a free valency or the like; and R2 is optionally substituted amino or the like.
一般公式(1)的化合物
R1—X1—W—X2—Z1—Z2—R2
或其盐,具有预防治疗HIV传染性疾病的作用,其中R1是可选地取代的五至六元环基团;X1是自由价电子或类似物;W是二价基团,例如,由一般公式(2)表示
(其中A和B各自是可选地取代的五至七元环;E1和E4各自是可选地取代的碳或类似物;E2和E3各自是氧或类似物;a和b各自是单键或双键);X2是构成直链部分的二价基团;Z1是二价环状基团或类似物;Z2是自由价电子或类似物;R2是可选地取代的氨基或类似物。